COMMUNIQUÉS West-GlobeNewswire

CytomX Therapeutics to Present at Upcoming March Investor Conferences
27/02/2024
SOUTH SAN FRANCISCO, Calif., Feb. 27, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, today announced that management will [...]
Adagene to Present at the Leerink Partners Global Biopharma Conference 2024
27/02/2024
SAN DIEGO and SUZHOU, China, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced its [...]
Korro to Present at the TD Cowen 44th Annual Health Care Conference
27/02/2024
CAMBRIDGE, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO) today announced that Chief Executive Officer and President, Ram Aiyar, Ph.D., will present at the TD Cowen 44 th Annual Health [...]
Pyxis Oncology Announces $50 Million Private Placement
27/02/2024
BOSTON, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: “PYXS”), a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, today announced [...]
PetVivo Holdings, Inc. Approved to Dual List on Upstream
27/02/2024
Trading to begin on March 5, 2024 under “PETV”, all shareholders to receive commemorative NFT MINNEAPOLIS, Feb. 27, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging [...]
Minerva Neurosciences Receives Complete Response Letter from FDA for New Drug Application for Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia
27/02/2024
BURLINGTON, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system [...]
Plus Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on March 5, 2024
27/02/2024
AUSTIN, Texas, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV ) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies [...]
Tonix Pharmaceuticals Announces Positive Results from Clinical Pharmacokinetic Bridging Study of Tonmya™ to Support Development and Partnering in Japan and China
27/02/2024
Tonix plans to File a Clinical Trial Notification (CTN) in Japan and Investigational New Drug (IND) application in China to support a registration-enabling Asian Phase 3 study without dosage adjustment based on U.S. [...]
Arcutis Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
27/02/2024
Q4 net product revenues for ZORYVE® (roflumilast) cream 0.3% were $13.5 million, a 357% increase compared to the fourth quarter of 2022 and a 67% increase compared to the third quarter of 2023; driven by sequential [...]
Crossject obtains a financing up to €12 million, in two tranches
27/02/2024
Dijon, February 27, 2024 at 8:30am Crossject obtains a financing up to €12 million, in two tranches, from an entity managed by Heights Capital Management, in issued bonds convertible in new shares, with a conversion [...]
Crossject obtient un financement jusqu’à 12 millions d’euros en 2 tranches
27/02/2024
Dijon, le 27 février 2024 à 08h30 Crossject obtient un financement jusqu’à 12 millions d’euros en 2 tranches, auprès d’une entité gérée par Heights Capital Management, sous forme d’émission d’obligations convertibles en [...]
Mendus to participate in upcoming industry conferences
27/02/2024
Press release Stockholm, Sweden, February 27, 2024 Mendus AB ("Mendus" publ; IMMU. ST), a biopharmaceutical company focused on immunotherapies targeting tumor recurrence, today announced that it will participate in the [...]
NEXSTIM PLC’S FINANCIAL STATEMENTS BULLETIN 2023
27/02/2024
Company announcement, Helsinki 27 February 2024 at 9 am (EET) NEXSTIM PLC’S FINANCIAL STATEMENTS BULLETIN 2023 NEXSTIM CONTINUED TO GROW COMPARABLE NET SALES WITH A RECORD YEAR-END July–December 2023 The company’s net [...]
Zealand Pharma convenes its Annual General Meeting 2024
27/02/2024
Company Announcement – No. 10 / 2024 Zealand Pharma convenes its Annual General Meeting 2024 Notice to convene the Annual General Meeting of Zealand Pharma A/S (CVR no. 20 04 50 78) (the "Company"). The Board of [...]
Zealand Pharma Announces Financial Results for the Full Year 2023
27/02/2024
Company announcement - No. 9 / 2024 Zealand Pharma Announces Financial Results for the Full Year 2023 Significant progress delivered across our obesity and rare disease assets while building a solid financial position [...]
Alira Health publie le rapport mondial 2024 sur la fabrication sous contrat dans le secteur des technologies médicales
27/02/2024
En 2023, le marché mondial de l’externalisation des technologies médicales, dites medtech, a progressé de plus de 11 % pour atteindre 81,5 milliards de dollars, ce qui témoigne d’une forte résilience du marché [...]
U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for Epcoritamab (EPKINLY®) for Difficult-to-Treat Relapsed or Refractory Follicular Lymphoma
27/02/2024
Media Release COPENHAGEN, Denmark; February 27, 2024 FDA grants Priority Review with target action date of June 28, 2024 Application based on results from Phase 1/2 EPCORE™ NHL-1 trial demonstrating clinically [...]
Bitterroot Bio and Biotheus Announce Research Collaboration to Develop Bispecific Proteins in Cardio-Immunology
27/02/2024
Collaboration aims to discover novel bispecific proteins targeting immune modulators and inflammatory pathways implicated in cardiovascular disease PALO ALTO, Calif., and ZHUHAI, China, Feb. 26, 2024 (GLOBE NEWSWIRE [...]
RTG Medical Ranks #70 on Inc. 5000 Regionals List in the Midwest
27/02/2024
FREMONT, Neb., Feb. 26, 2024 (GLOBE NEWSWIRE) -- RTG Medical, a leading healthcare staffing agency, has been recognized as one of the top performers in the Midwest, securing the impressive #70 spot on the prestigious [...]

Pages